Premium
P4–310: Preclinical characterization of a selective alpha‐7 neuronal nicotinic acetylcholine receptor agonist ABT‐126: A novel therapeutic agent for the treatment of cognitive impairment in Alzheimer's disease and schizophrenia
Author(s) -
Bitner Robert,
Anderson David,
Drescher Karla,
Kohlhaas Kathy,
Gronlien Halvard,
Hu Min,
Li Jinhe,
Markosyan Stella,
Marsh Kennan,
Mohler Eric,
Nikkel Arthur,
Radek Richard,
Robb Holly,
Schrimpf Michael,
Waring Jeffrey,
Lee ChihHung,
Gopalakrishnan Murali
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.05.1755
Subject(s) - neuroscience , pharmacology , nicotinic agonist , hippocampal formation , agonist , medicine , psychology , receptor